Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction

被引:13
作者
Chandler, Emmanuel [1 ]
Ding, Lili [1 ]
Gorbach, Pamina [2 ]
Franco, Eduardo L. [3 ,4 ]
Brown, Darron A. [5 ]
Widdice, Lea E. [1 ]
Bernstein, David I. [1 ]
Kahn, Jessica A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA
[2] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA
[3] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[4] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[5] Indiana Univ, Dept Med, Indianapolis, IN USA
基金
美国国家卫生研究院;
关键词
Human papillomavirus; Vaccines; Young men; Sexually transmitted infections; UNITED-STATES; RISK-FACTORS; CONDOM USE; SEXUAL-BEHAVIORS; INFECTION; PREVALENCE; ASSOCIATION; DISEASE; HIV; PERCEPTIONS;
D O I
10.1016/j.jadohealth.2018.01.005
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Purpose: The aims of this study were to determine prevalence of and factors associated with any human papillomavirus (HPV) and vaccine-type HPV among young men after vaccine introduction, stratified by vaccination status. Methods: Young men were recruited from clinical sites from 2013 to 2015, completed a survey, and were tested for 36 anogenital HPV types. We determined factors associated with >= 1 HPV type among all participants, and vaccine-type HPV (HPV6, 11, 16, and/or 18) among all, vaccinated and unvaccinated participants, using multivariable regression. Results: Mean age was 21.5 years and 26% had received at least one HPV vaccine dose. HPV prevalence was lower in vaccinated versus unvaccinated young men (50.5% vs. 62.6%, p = .03). HPV positivity was discordant by anogenital site. At both sites, 59.4% were positive for >= 1 HPV type and 26.0% for >= 1 4-valent vaccine type. In multivariable logistic regression, factors associated with >= 1 HPV type among all participants were frequency of oral sex (odds ratio [OR] = 1.80, 95% confidence interval [CI] = 1.00-3.24), recent smoking (OR = 1.84, CI = 1.17-2.90), and sexually transmitted infection history (OR = 1.56, CI = 1.02-2.38). Factors associated with vaccine-type HPV among all participantswere white versus black race (OR = 1.91, CI = 1.10-3.34) and gonorrhea history (OR = 2.52, CI = 1.45-4.38); among vaccinated participants were private versus Medicaid insurance (OR = 5.6, CI = 1.46-20.4) and private versus no insurance (OR = 15.9, CI = 3.06-83.3); and among unvaccinated participants was gonorrhea history (OR = 1.83, CI = 1.03-3.24). Conclusions: Anogenital HPV prevalence was high and vaccination rates low among young men 2-4 years after vaccine introduction, underscoring the urgency of increasing vaccination rates and vaccinating according to national guidelines. (c) 2018 Society for Adolescent Health and Medicine. All rights reserved.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 39 条
[1]  
[Anonymous], AM J MENS HLTH
[2]  
[Anonymous], 2014, INT J CANCER, DOI DOI 10.1002/ijc.28567
[3]   Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic [J].
Baldwin, SB ;
Wallace, DR ;
Papenfuss, MR ;
Abrahamsen, M ;
Vaught, LC ;
Giuliano, AR .
SEXUALLY TRANSMITTED DISEASES, 2004, 31 (10) :601-607
[4]   HPV Prevalence in Multiple Anatomical Sites among Men Who Have Sex with Men in Peru [J].
Blas, Magaly M. ;
Brown, Brandon ;
Menacho, Luis ;
Alva, Isaac E. ;
Silva-Santisteban, Alfonso ;
Carcamo, Cesar .
PLOS ONE, 2015, 10 (10)
[5]   Influence of Partner's Infection Status on Prevalent Human Papillomavirus Among Persons With a New Sex Partner [J].
Burchell, Ann N. ;
Tellier, Pierre-Paul ;
Hanley, James ;
Coutlee, Francois ;
Franco, Eduardo L. .
SEXUALLY TRANSMITTED DISEASES, 2010, 37 (01) :34-40
[6]  
Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1705
[7]   NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in US Men [J].
Chaturvedi, Anil K. ;
Graubard, Barry I. ;
Broutian, Tatevik ;
Pickard, Robert K. L. ;
Tong, Zhen-yue ;
Xiao, Weihong ;
Kahle, Lisa ;
Gillison, Maura L. .
CANCER RESEARCH, 2015, 75 (12) :2468-2477
[8]   Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study [J].
Chow, Eric P. F. ;
Machalek, Dorothy A. ;
Tabrizi, Sepehr N. ;
Danielewski, Jennifer A. ;
Fehler, Glenda ;
Bradshaw, Catriona S. ;
Garland, Suzanne M. ;
Chen, Marcus Y. ;
Fairley, Christopher K. .
LANCET INFECTIOUS DISEASES, 2017, 17 (01) :68-77
[9]   Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis [J].
Drolet, Melanie ;
Benard, Elodie ;
Boily, Marie-Claude ;
Ali, Hammad ;
Baandrup, Louise ;
Bauer, Heidi ;
Beddows, Simon ;
Brisson, Jacques ;
Brotherton, Julia M. L. ;
Cummings, Teresa ;
Donovan, Basil ;
Fairley, Christopher K. ;
Flagg, Elaine W. ;
Johnson, Anne M. ;
Kahn, Jessica A. ;
Kavanagh, Kimberley ;
Kjaer, Susanne K. ;
Kliewer, Erich V. ;
Lemieux-Mellouki, Philippe ;
Markowitz, Lauri ;
Mboup, Aminata ;
Mesher, David ;
Niccolai, Linda ;
Oliphant, Jeannie ;
Pollock, Kevin G. ;
Soldan, Kate ;
Sonnenberg, Pam ;
Tabrizi, Sepehr N. ;
Tanton, Clare ;
Brisson, Marc .
LANCET INFECTIOUS DISEASES, 2015, 15 (05) :565-580
[10]   Prevalence of HPV infection among men: A systematic review of the literature [J].
Dunne, Eileen F. ;
Nielson, Carrie M. ;
Stone, Katherine M. ;
Markowitz, Lauri E. ;
Giuliano, Anna R. .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (08) :1044-1057